| Literature DB >> 31905888 |
Yair Olovaldo Santiago-Saenz1, Rebeca Monroy-Torres2, Diana Olivia Rocha-Amador3, Alma Delia Hernández-Fuentes1.
Abstract
Quelites are Mexican wild plants, reported as excellent sources of nutritional compounds such as amino acids (serine, glycine, and cysteine), minerals (Mg, Fe, and Zn), and phytochemicals, as phenolic acids (chlorogenic acid) and flavonoids (phloridzin and naringenin); on the other hand, high biological activity has been shown in these compounds. This work aimed to evaluate the effect of a supplementation with two endemic quelites of Mexico (Chenopodium berlandieri L. and Portulaca Oleracea L.); in addition to supplementation, a nutritional intervention was performed; the biomarkers of hemoglobin (Hb), urinary malondialdehyde (UMDA), and urinary arsenic (UAs) were measured in adolescents exposed to arsenic. A clinical intervention study was conducted in 27 adolescents ages 11 to 12 years for 4 weeks. Weekly anthropometric and dietary evaluations were carried out, as well as the concentration of Hb; the UMDA and UAs were performed by plate-based colorimetric measurement and atomic absorption spectrophotometry with the hydrides generation system, respectively. The results showed that UMDA concentrations had a significant improvement in the supplemented group (SG) vs. control group (CG) (SG = 1.59 ± 0.89 µM/g creatinine vs. CG = 2.90 ± 0.56 µM/g creatinine) in the second week of intervention; on the other hand, the supplemented group showed an increase in Hb levels (15.12 ± 0.99 g/dL) in the same week; finally after the second week, an increase in UAs levels was observed significantly compared to the baseline value (Baseline: 56.85; Week 2: 2.02 µg/g creatinine). Therefore, the results show that the mixture of quelites (a rich source of phytochemicals and nutrients) improved hemoglobin and UMDA levels, and urinary arsenic excretion from the second week in the exposed population.Entities:
Keywords: arsenic; quelites; supplementation
Mesh:
Substances:
Year: 2019 PMID: 31905888 PMCID: PMC7019896 DOI: 10.3390/nu12010098
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Flow diagram of patient progress through the phases of the randomized trial.
General characteristics of participants of the supplemented and control group.
| Baseline Variables | Supplemented | Control | |
|---|---|---|---|
| Age (years) | 11.80 ± 0.41 | 12 ± 0.36 | 3 NS |
| Weight (kg) | 47.31 ± 10.54 | 48.95 ± 11.33 | NS |
| Height (cm) | 150.31 ± 6.74 | 153.30 ± 7.21 | NS |
| 1 H/A interpretation (Z-Score) | NS | ||
| Normal height | 15 ± 82.19 | 12 ± 91.42 | |
| 2 BMI interpretation (Z-Score) | NS | ||
| Obesity | 2 ± 10.14 | 2 ± 16.05 | |
| Overweight | 5 ± 33.67 | 3 ± 19.36 | |
| Normal weight | 8 ± 31.94 | 7 ± 35.02 | |
| Fat mass (%) | 21.92 ± 14.71 | 23.02 ± 14.07 | NS |
| Muscular mass (%) | 33.46 | 32.12 ± 8.95 | NS |
| Waist circumference (cm) | 71.19 ± 12.05 | 71.48 ± 9.44 | NS |
| Abdominal circumference (cm) | 76.28 ± 11.58 | 79.33 ± 10.27 | NS |
The table shows the mean ± standard deviation (SD) for each baseline variable and the p-value according to the independent samples t-Test (p < 0.05). 1 H/A: height-for-age [ages 5–19 years (Z-Score)]; 2 BMI: body mass index for age [ages 5–19 years (Z-Score)]; 3 NS: not significant.
General characteristics for men, women, and total participants included in the supplementation study.
| Baseline Variables | Total Population | Men | Women | |
|---|---|---|---|---|
| Age (years) | 11.88 ± 0.32 | 11.84 ± 0.37 | 11.92 ± 0.26 | 3 NS |
| Weight (kg) | 48.13 ± 10.72 | 48.07 ± 10.89 | 48.19 ± 10.98 | NS |
| Height (cm) | 151.78 ± 7.01 | 152.56 ± 7.28 | 151.00 ± 6.64 | NS |
| 1 H/A interpretation (Z-Score) | NS | |||
| Normal height | 27 ± 98.42 | 13 ± 86.24 | 14 ± 93.37 | |
| 2 BMI interpretation (Z-Score) | NS | |||
| Obesity | 4 ± 31.26 | 1 ± 9.32 | 3 ± 17.21 | |
| Overweight | 8 ± 35.74 | 5 ± 35.11 | 3 ± 21.17 | |
| Normal weight | 15 ± 42.31 | 8 ± 32.29 | 7 ± 35.18 | |
| Fat mass (%) | 22.46 ± 14.16 | 13.98 ± 12.64 | 30.32 ± 10.74 | <0.001 |
| Muscular mass (%) | 32.80 ± 10.03 | 40.47 | 25.67 ± 2.93 | <0.001 |
| Waist circumference (cm) | 71.34 ± 10.77 | 71.20 ± 11.77 | 71.47 ± 10.20 | NS |
| Abdominal circumference (cm) | 77.81 ± 10.96 | 75.62 ± 10.90 | 79.84 ± 11.01 | NS |
The table shows the mean ± standard deviation (SD) for each baseline variable and the p-value according to the independent samples t-Test (p < 0.05). 1 H/A: height-for-age in men and women ages 5–19 years (Z-Score); 2 BMI: body mass index for age in men and women ages 5–19 years (Z-Score); 3 NS: not significant.
Daily intake of energy and nutrients in supplemented and control group.
| Nutrients | Supplemented | Control | |
|---|---|---|---|
| Energy (kcal) | 2006.04 ± 5.07 | 2000.12 ± 3.49 | <0.002 |
| Protein (g) | 70.05 ± 27.52 | 69.96 ± 27.96 | 1 NS |
| Fat (g) | 70.02 ± 33.71 | 66.15 ± 29.66 | NS |
| Cholesterol (mg) | 284.21 ± 169.46 | 282.59 ± 180.64 | NS |
| Carbohydrates (g) | 290.38 ± 96.12 | 273.41 ± 51.34 | NS |
| Sugar (g) | 32.36 ± 31.67 | 30.02 ± 36.32 | NS |
| Fiber (g) | 21.09 ± 12.20 | 20.17 ± 8.91 | NS |
| Vitamin A-Retinol (µg) | 767.04 ± 182.09 | 753.62 ± 173.48 | NS |
| Vitamin B1(mg) | 1.15 ± 0.50 | 1.09 ± 0.38 | NS |
| Vitamin B2 (mg) | 1.23 ± 0.57 | 1.21 ± 0.45 | NS |
| Vitamin B6 (mg) | 0.94 ± 0.55 | 0.81 ± 0.46 | NS |
| Vitamin B12 (µg) | 1.93 ± 1.12 | 1.91 ± 1.27 | NS |
| Vitamin C (mg) | 52.47 ± 45.74 | 34.03 ± 29.79 | NS |
| Folic acid (µg) | 186.39 ± 174.18 | 136.25 ± 88.08 | NS |
| Niacin (mg) | 12.28 ± 6.60 | 9.08 ± 5.67 | NS |
| Vitamin E (mg) | 2.67 ± 2.01 | 1.97 ± 3.73 | NS |
| Ca (mg) | 947.59 ± 361.72 | 937.66 ± 363.81 | NS |
| Fe (mg) | 14.82 ± 7.30 | 13.29 ± 4.43 | NS |
| K (mg) | 1605.14 ± 654.99 | 1094.35 ± 566.09 | <0.05 |
| Mg (mg) | 303.39 ± 220.35 | 240.26 ± 184.69 | NS |
| Na (mg) | 2501.90 ± 811.04 | 1949.78 ± 721.42 | NS |
| P (mg) | 631.40 ± 304.63 | 595.08 ± 264.43 | NS |
| Se (µg) | 51.95 ± 30.00 | 50.06 ± 23.06 | NS |
| Zn (mg) | 4.68 ± 2.60 | 4.26 ± 2.00 | NS |
The values show the mean ± SD for each nutrient and the p-value according to the independent samples t-Test (p < 0.05). 1 NS: not significant.
Daily intake of energy and nutrients of all adolescents and by group (men and women) included in the supplementation study.
| Nutrients | Total Population | Men | Women | |
|---|---|---|---|---|
| Energy (kcal) | 2003.07 ± 1.24 | 2345.11 ± 1.35 | 1490 ± 1.11 | <0.001 |
| Protein (g) | 70.24 ± 32.01 | 87.84 ± 27.96 | 43.85 ± 19.88 | <0.001 |
| Fat (g) | 68.19 ± 29.36 | 81.03 ± 26.83 | 48.93 ± 8.62 | <0.001 |
| Cholesterol (mg) | 283.63 ± 127.38 | 398.28 ± 142.17 | 111.67 ± 101.48 | <0.001 |
| Carbohydrates (g) | 281.85 ± 82.19 | 321.01 ± 72.98 | 223.13 ± 27.13 | <0.001 |
| Sugar (g) | 31.07 ± 29.70 | 38.01 ± 36.21 | 20.65 ± 14.98 | 1 NS |
| Fiber (g) | 20.64 ± 8.56 | 22.81 ± 10.68 | 17.39 ± 3.81 | NS |
| Vitamin A-Retinol (µg) | 759.60 ± 128.11 | 877.67 ± 143.62 | 582.50 ± 105.69 | <0.001 |
| Vitamin B1(mg) | 1.13 ± 0.54 | 1.41 ± 0.52 | 0.69 ± 0.11 | <0.001 |
| Vitamin B2 (mg) | 1.22 ± 0.65 | 1.60 ± 0.55 | 0.64 ± 0.30 | <0.001 |
| Vitamin B6 (mg) | 0.87 ± 0.56 | 1.11 ± 0.50 | 0.50 ± 0.34 | <0.001 |
| Vitamin B12 (µg) | 1.92 ± 1.10 | 2.46 ± 1.01 | 1.11 ± 0.88 | <0.001 |
| Vitamin C (mg) | 43.30 ± 44.13 | 52.41 ± 50.86 | 29.65 ± 11.81 | NS |
| Folic acid (µg) | 161.33 ± 198.05 | 235.89 ± 219.80 | 49.49 ± 21.16 | <0.002 |
| Niacin (mg) | 10.69 ± 6.75 | 13.97 ± 6.61 | 5.76 ± 1.50 | <0.001 |
| Vitamin E (mg) | 2.33 ± 1.80 | 2.67 ± 1.80 | 1.82 ± 1.87 | NS |
| Ca (mg) | 942.63 ± 270.27 | 1133.50 ± 332.51 | 656.33 ± 255.79 | <0.001 |
| Fe (mg) | 14.10 ± 9.59 | 18.31 ± 9.57 | 7.79 ± 2.49 | <0.001 |
| K (mg) | 1349.47 ± 436.12 | 1597.94 ± 445.58 | 976.75 ± 407.24 | <0.001 |
| Mg (mg) | 271.83 ± 222.07 | 328.83 ± 238.09 | 186.33 ± 164.75 | NS |
| Na (mg) | 2226.77 ± 658.33 | 2993.61 ± 776.12 | 1076.50 ± 501.16 | <0.001 |
| P (mg) | 613.67 ± 307.02 | 754 ± 220.09 | 403.17 ± 225.73 | <0.001 |
| Se (µg) | 51.33 ± 29.33 | 67.56 ± 19.44 | 27 ± 14.33 | <0.001 |
| Zn (mg) | 4.46 ± 2.94 | 5.99 ± 2.49 | 2.15 ± 1.37 | <0.001 |
The values show the mean ± SD for each nutrient and the p-value according to the independent samples t-Test (p < 0.05). 1 NS: not significant.
Figure 2Concentrations of (a) Hb (Hemoglobin) (mean ± SD) and (b) UMDA (Urinary malondialdehyde) (mean ± SD) before, during, and after 4 weeks of supplementation in the supplemented and control group (W0: baseline; W1: week 1; W2: week 2; W3: week 3; W4: week 4). * Statistically significant difference between groups according to the independent samples t-Test (p < 0.001).
Urinary MDA concentrations in men, women, and total participants before, during, and after 4 weeks of supplementation.
| Supplement | Men | Women | Control | Men | Women | |||
|---|---|---|---|---|---|---|---|---|
| Weeks | Urinary MDA concentrations (µM/g creatinine) | |||||||
| Baseline | 3.01 ± 0.85 | 3.26 ± 0.97 | 2.63 ± 0.48 | NS | 2.88 ± 0.61 | 3.44 ± 0.35 | 2.59 ± 0.51 | <0.014 |
| 2 | 1.59 ± 0.89 | 1.84 ± 1.06 | 1.21 ± 0.36 | NS | 2.90 ± 0.56 | 3.47 ± 0.39 | 2.61 ± 0.38 | <0.004 |
| 4 | 0.98 ± 0.80 | 1.13 ± 1.01 | 0.75 ± 0.28 | NS | 2.94 ± 0.57 | 3.51 ± 0.26 | 2.66 ± 0.44 | <0.006 |
The values show the mean ± SD of UMDA (Urinary malondialdehyde) concentrations (µM/g creatinine) in supplemented and the control group before, during and after 4 weeks of supplementation. The week zero represents baseline. NS: no statistically significant difference between men and women of the same group per week according to the independent samples t-Test.
Urinary MDA concentrations in men of the supplemented and control group and women of the supplemented and control group, before, during, and after 4 weeks of supplementation.
| Men | Control | Women | Control | |||
|---|---|---|---|---|---|---|
| Weeks | Urinary MDA concentrations (µM/g creatinine) | |||||
| Baseline | 3.26 ± 0.97 | 3.44 ± 0.35 | NS | 2.63 ± 0.48 | 2.59 ± 0.51 | NS |
| 2 | 1.84 ± 1.06 | 3.47 ± 0.39 | <0.014 | 1.21 ± 0.36 | 2.61 ± 0.38 | <0.001 |
| 4 | 1.13 ± 1.01 | 3.51 ± 0.26 | <0.001 | 0.75 ± 0.28 | 2.66 ± 0.44 | <0.001 |
The values show the mean ± SD of UMDA (Urinary malondialdehyde) concentrations (µM/g creatinine) in men of supplemented and control group and women of supplemented and control group, before, during and after 4 weeks of supplementation. The week zero represents baseline. NS: no statistically significant difference between men of supplemented and control group and women of supplemented and control group per week according to the independent samples t-Test.
Urinary As concentrations in the supplemented and control group during 4 weeks of supplementation.
| Supplemented | Men | Women | Control | Men | Women | |||
|---|---|---|---|---|---|---|---|---|
| Weeks | Urinary As concentrations (µg/g creatinine) | |||||||
| 0 | 56.85 | 57.42 | 52.09 | NS | 51.34 | 53.98 | 50.81 | NS |
| 1 | 53.60 | 53.90 | 53.48 | NS | 52.57 | 53.13 | 52.19 | NS |
| 2 | 2.02 | 3.95 | 0.45 | NS | 56.49 | 58.62 | 54.02 | NS |
| 3 | 0.29 | 0.27 | 0.30 | NS | 50.97 | 54.53 | 49.76 | <0.05 |
| 4 | 0.29 | 0.27 | 0.30 | NS | 54.60 | 54.78 | 54.45 | NS |
The values show the median of UAs (Urinary arsenic) concentrations (µg/g creatinine) in the supplemented and control group. The week zero represents baseline. NS: no statistically significant difference between men and women of the same group per week according to the Mann–Whitney U test.
Figure 3UAs (Urinary arsenic) (median) concentration by sex in the supplemented group (a) and control group (b) (W0: baseline; W1: week 1; W2: week 2; W3: week 3; W4: week 4). * Statistically significant difference by sex according to the Mann–Whitney U test (p < 0.05).
Figure 4(a) Comparison of UAs (Urinary arsenic) concentrations (median) in the supplemented group and control group (W0: baseline; W1: week 1; W2: week 2; W3: week 3; W4: week 4). ** Statistically significant difference between groups according to the Mann–Whitney U test (p < 0.001); (b) Comparison of UAs concentration (median) between supplemented and control group per week of treatment. The Friedman and Wilcoxon tests were carried out to determine differences between weeks of supplementation.